glp-1 and neuroinflammation A schematic representation of the mechanism of glucagon-like peptide-1 GLP-1 for Weight Loss and

Right now, its unclear how Ozempic may increase the risk of vision loss caused by NAION

In the SURMOUNT-1 trial, tirzepatide 15 mg weekly achieved 20.9% WL over 72 weeks (vs

In summary, focusing on innovative delivery technologies like these highlights an alternative path to ultra-long-acting GLP1 therapy one that leverages how the drug is delivered rather than what the drug is, potentially simplifying development and complementing the ongoing efforts with new GLP1 analogs

For customers who may be using GLP-1s, the one-on-one attention that coaches provide can be an effective way to sustain a healthy and active lifestyle routine while using and after they stop using GLP-1s

These changes will affect fully insured large group commercial members, with a significant shift coming on January 1, 2025, when coverage for these medications will be discontinued altogether